Skip to content
OpenCapital
Get started

Envoy Medical COCH Cash & Equivalents

Cash & Equivalents at other companies

Inspire Medical Systems logo
Inspire Medical SystemsINSP
$98.93M+83.6%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K—
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+93.3%
P/S260.7×+119×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%—
Debt / equity0.1×—
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:Cash.

The official record: Envoy Medical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's cash & equivalents?
Envoy Medical (COCH) reported cash & equivalents of $25.25M in Q1 2026.
How has Envoy Medical's cash & equivalents changed year-over-year?
Envoy Medical's cash & equivalents increased by 376.4% year-over-year, from $5.3M to $25.25M.
What is the long-term trend for Envoy Medical's cash & equivalents?
Over 5 years (2020 to 2025), Envoy Medical's cash & equivalents has grown at a 172.2% compound annual growth rate (CAGR), from $25K to $3.74M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.